Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...

More documents

Recommendations

Info

o Michelle McRobbie University of Oxford, UK Genetic pathways for the prediction of the effects of ionising radiation: low dose radiosensitivity and risk to normal tissue after radiotherapy o Nada Khan University of Oxford, UK Late effects associated with treatments for breast, colorectal and prostate cancer: a matched cohort study using the General Practice Research Database and National Cancer Intelligence Network 26
Parallel sessions in detail Wednesday Brain tumours Hosted by Susan Short University College Hospital, London, UK o Susan Short University College Hospital, London, UK Introduction o Rossella Galli Stem cell Research Institute, Milan, Italy Functional and molecular characterisation of cancer stem cells from brain tumours o Walter Stummer University of Dusseldorf, Germany Issues in the surgical therapy of malignant gliomas o Anca Grosu University of Freiburg, Germany PET imaging and glioma Proffered paper presentations: o Talal Fael Al-Mayhani University of Cambridge, UK NG2 expression identifies a cell population capable of maintaining tumour growth in glioblastoma o Simone Wilkins University of Liverpool, UK Vascularity in regions of highest choline predicts progression in low grade astrocytomas o Mausam Singhera University College London, UK Outcome in a 2-year cohort of brain metastases patients treated in a specialist multi-disciplinary clinic at UCLH Economics of drug development and provision Hosted by Sir Kenneth Calman 1 and David Ardron 2 1 2 University of Glasgow, UK; and NCRI Consumer Liaison Group o Sir Kenneth Calman 1 and David Ardron 2 1 University of Glasgow, UK; and 2 NCRI Consumer Liaison Group, UK Introduction o Alison Clough The Association of the British Pharmaceutical Industry, London, UK Life and medicines: price and value o Elisabeth George National Institute for Health and Clinical Excellence, London, UK Appraising cancer drugs at the National Institute for Clinical and Health Excellence o David Gillen Pfizer, UK The challenge for the pharmaceutical industry in the 21st century: discovery, development and access to medicines in a distrustful environment o Martin Gore The Institute of Cancer Research and Royal Marsden Hospital, Sutton, UK Title to be confirmed 27
Page 1 and 2: seymour 1
Page 3 and 4: Programme at a glance Sunday 12.15
Page 5 and 6: 14.30 - 15.30 Workshops • How to
Page 7 and 8: Programme at a glance Tuesday 08.00
Page 9 and 10: Programme at a glance Wednesday 08.
Page 11 and 12: Symposia in detail Tuesday 30 th An
Page 13 and 14: o Brijesh Madhok University of Leed
Page 15 and 16: o Henrik Møller King's College Lon
Page 17 and 18: o Catherine Kelly CRUK-MRC Gray Ins
Page 19 and 20: o Joerg Hoheisel German Cancer Rese
Page 21 and 22: Proffered paper presentations: o CR
Page 23 and 24: o Simon Gayther University Departme
Page 25: Senescence and autophagy as an appr
Page 29 and 30: o Steven Walker Almac Diagnostics,
Page 31 and 32: o Mike Bennett University of Lancas
Page 33 and 34: Proffered paper presentations: o Ja
Page 35 and 36: Workshops & debates in detail Monda
Page 37 and 38: presentations, the workshop will be
Page 39 and 40: o Andrew Ritchie NCRI Complementary
Page 41: 1. Clinical Research and Developmen

Programme (PDF) - (NCRI) Cancer Conference 2013 - National ...

Create successful ePaper yourself

Delete template?

Save as template?